Advertisement

The Hepatorenal Syndrome (HRS)

  • Murray Epstein
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 212)

Abstract

Progressive oliguric renal failure commonly complicates the course of patients with advanced hepatic disease (1,2). While this condition has been designated by many names including “functional renal failure”, and “the renal failure of cirrhosis”, the more appealing albeit less specific term “hepatorenal syndrome” has been utilized commonly to describe this syndrome. For the purposes of this discussion, the hepatorenal syndrome may be defined as unexplained progressive renal failure occurring in patients with liver disease in the absence of clinical, laboratory, or anatomic evidence of other known causes of renal failure.

Keywords

Cirrhotic Patient Sympathetic Nervous System Activity Hepatorenal Syndrome Renal Vasoconstriction Renal Hypoperfusion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    S. Papper S, Hepatorenal Syndrome, in: “The Kidney in Liver Disease” M. Epstein, 2. ed Elsevier, New York, pp. 87 (1983).Google Scholar
  2. 2.
    M. Epstein, Hepatorenal syndrome, In: “Bockus Gastroenterology”, 4th edition, edited by J.E. Berk, Saunders, Philadelphia, pp. 3138 (1985).Google Scholar
  3. 3.
    M. Epstein, J.R. Oster, R.E. DeVelasco, Hepatorenal syndrome following hemihepatectomy. Clin. Nephrol. 5: 128 (1976).Google Scholar
  4. 4.
    D.J. Ritt, G. Whelan, D.J. Werner, E.H. Eigenbrodt, S. Schenker,B. Combes, Acute hepatic necrosis with stupor or coma. Medicine 48: 151 (1969).PubMedCrossRefGoogle Scholar
  5. 5.
    P. Vesin, A. Roberti, R.R. Viguie. Defaillance renale fonctionnell terminale chez des malades atteints de cancer du foie, primitif ou secondaire. Sem. Hop. Paris, 26: 1216 (1965).Google Scholar
  6. 6.
    M.A. Papadakis, A.I. A.ieff. Progressive deterioration of renal function in non-azotemic cirrhotic patients with ascites: A prospective study. Kidney Int. 27: 149 (1985) (Abstract).Google Scholar
  7. 7.
    L. Shear, J. Kleinerman, G.J. Gabuzda, Renal failure in patients with cirrhosis of the liver. I. Clinical and pathologic characteristics. Am. J. Med. 39: 184 (1965).Google Scholar
  8. 8.
    H. Goldstein, J.D. Boyle, Spontaneous recovery from the hepatorenal syndrome. Report of four cases. N. Engl. J. Med. 272: 895 (1965).PubMedCrossRefGoogle Scholar
  9. 9.
    M.H. Koppel, J.W. Cobrun, M.M. Mims, H. Goldstein, J.D. Boyle, M.E. Rubini, Transplantation of cadaveric kidneys from patients with hepatorenal syndrome. Evidence for the functional nature of renal failure in advanced liver disease. N. Engl. J. Med. 280: 1367 (1969).PubMedCrossRefGoogle Scholar
  10. 10.
    M. Epstein, D.P. Berk, N.K. Hollenberg, D.F. Admas, T.C. Chalmers, H.L. Abrams, J.P. Merrill, Renal failure in the patient with cirrhosis. The role of active vasoconstriction. Am. J. Med. 49: 175 (1970).PubMedCrossRefGoogle Scholar
  11. 11.
    M.C. Kew, R.R. Varma, H.S. Willimas, P.W. Brunt, K.J. Hourigan, S. Sherlock, Renal and intrarenal blood flow in cirrhosis of the liver. Lancet 2: 504 (1971).PubMedCrossRefGoogle Scholar
  12. 12.
    E.T. Schroeder, L. Shear, S.M. Sancetta, G.J. Gabuzda, Renal failure in patients with cirrhosis of the liver. III. Evaluation of intrarenal blood flow by para-amino-hippurate extraction and response to angiotensin. Am. J. Med. 43: 887 (1967).PubMedCrossRefGoogle Scholar
  13. 13.
    N.K. Hollenberg, M. Epstein, R.I. Basch, D.E. Oken, J.P. Merrill, Acute oliguric renal failure in man: Evidence for preferential renal cortical ischemia. Medicine, 47: 455 (1968).PubMedCrossRefGoogle Scholar
  14. 14.
    N.K. Hollenberg, Renin, angiotensin and the kidney: Assessment by pharmacological interruption of the renin-angiotensin system, In: The Kidney in Liver Disease, 2nd Edition, edited by M. Epstein, Elsevier, New York, pp. 395 (1983).Google Scholar
  15. 15.
    E.T. Schroeder, R.H. Eich, H. Smulyan, A.B. Gould, G.J. Gabuzda, Plasma renin level in hepatic cirrhosis. Am. J. Med. 49: 186 (1970).PubMedCrossRefGoogle Scholar
  16. 16.
    M. Epstein, Renal prostaglandins and the control of renal function in liver disease. Am. J. Med. 80: (Suppl 1A)46–55 (1986).PubMedCrossRefGoogle Scholar
  17. 17.
    A.I. Arieff, C.A. Chidsey, Renal function in cirrhosis and the effects of prostaglandin Al. Am. J. Med. 56: 695 (1974).PubMedCrossRefGoogle Scholar
  18. 18.
    J.C. McGiff, H.D. Itskovitz, Prostaglandins and the kidney. Circ. Res., 33: 479 (1973).PubMedCrossRefGoogle Scholar
  19. 19.
    T.D. Boyer, P. Zia, T.B. Reynolds, Effect of indomethacin and prostaglandin Al on renal function and plasma renin activity in alcoholic liver disease. Gastroenterology 77: 215 (1979).PubMedGoogle Scholar
  20. 20.
    R.D. Zipser, J.C. Hoefs, P.F. Speckart, P.K. Zia, R. Horton, Prostaglandins: modulators of renal function and pressor resistance in chronic liver disease. J. Clin. Endocrinol. Metab. 48: 895 (1979).PubMedCrossRefGoogle Scholar
  21. 21.
    R.D. Zipser, G.H. Radvan, K.J. Kronborg, et al. Urinary thromboxane B2 and prostaglandin E2 in the hepatorenal syndrome: Evidence for increased vasoconstrictor and decreased vasodilator factors. Gastroenterology 84: 697 (1983).PubMedGoogle Scholar
  22. 22.
    R.D. Zipser, I. Kronborg, W. Rector, et al. Therapeutic trial of thromboxane synthesis inhibition in the hepatorenal syndrome. Gastroenterology 87: 1228 (1984).PubMedGoogle Scholar
  23. 23.
    D.T. O’Connor, and R.A. Stone, The renal kallikrein-kinin system: Description and relationship to liver disease, in: The Kidney in Liver Disease, 2nd ed. M. Epstein, Elsevier, New York pp. 469 (1983).Google Scholar
  24. 24.
    M.D. Thames, Neural control of renal function: Contribution of cardiopulmonary baroreceptors to the control of the kidney. Fed. Proc. 37: 1209 (1977).Google Scholar
  25. 25.
    G.F. DiBona, Renal neural activity in hepatorenal syndrome. Kidney Int. 25: 841 (1984).PubMedCrossRefGoogle Scholar
  26. 26.
    A. Gatta, C. Merkel, M. Grassetto, L. Milani, R. Zuin, A. Rual, Enhanced renal sympathetic tone in liver cirrhosis: evaluation by intrarenal administration of dihydroergocristine. Nephron 30: 364 (1982).PubMedCrossRefGoogle Scholar
  27. 27.
    M. Epstein, 0. Larios, G. Johnson, Effects of water immersion on plasma catecholamines in decompensated cirrhosis. Implications for deranged sodium and water homeostasis. Mineral & Electrolyte Metab 11: 25 (1985).Google Scholar
  28. 28.
    D.B. Bichet, V.J. VanPutten, R.W. Schrier, Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis. New. Engl. J. Med. 307: 1552, (1982).PubMedCrossRefGoogle Scholar
  29. 29.
    J.H. Henriksen, H. Ring-Larsen, I-L Kanstrup, N.J. Christensen., Splanchnic and renal elimination and release of catecholamines in cirrhosis. Evidence of enhanced sympathetic nervous activity in patients with decompensated cirrhosis. Gut. 25: 1034 (1984).PubMedCrossRefGoogle Scholar
  30. 30.
    M.Epstein, Renal effects of head-out water immersion in man. Implications for an understanding of volume homeostasis. Physiol. Rev. 58: 529 (1978).PubMedGoogle Scholar
  31. 31.
    H. Liehr, and A.I. Jacob, Endotoxin and renal failure in liver disease, in: The Kidney in Liver Disease, 2nd ed. edited by M. Epstein, Elsevier, New York, pp. 535 (1983).Google Scholar
  32. 32.
    C. Clemente, J. Bosch, J. Rodes, V. Arroyo, A. Mas, S. Maragall, Functional renal failure and haemorrhagic gastritis associated with endotoxaemia in cirrhosis. Gut 18: 556 (1977).PubMedCrossRefGoogle Scholar
  33. 33.
    A. Gatta, L. Milani, C. Merkel, R. Zuin, P. Amodio, L. Caregaro, A. Ruol, Lack of correlation between endotoxemia and renal hypoperfusion in cirrhotics without overt renal failure. Eur. J. Clin. Invest. 12: 417 (1982).PubMedCrossRefGoogle Scholar
  34. 34.
    P. Coratelli, G. Passavanti, I. Munno, D. Fumarola, A. Amerio, New trends in hepatorenal syndrome. Kidney Int. 28:S-143 (1985).Google Scholar
  35. 35.
    A. Alvestrand, J. Bergstrom, Glomerular hyperfiltration after protein ingestion, during glucagon infusion, and in insulin-dependent diabetes is induced by a liver hormone: Deficientproduction of this hormone in hepatic failure causes hepatorenal syndrome. Lancet 1: 195 (1984).Google Scholar

Copyright information

© Plenum Press, New York 1987

Authors and Affiliations

  • Murray Epstein
    • 1
  1. 1.Division of NephrologyUniversity of Miami School of Medicine and Veterans Administration Medical CenterMiamiUSA

Personalised recommendations